Weight-Loss surgery Outperforms GLP-1 Drugs for Long-Term Health in obese Patients with Diabetes, Landmark Study Finds
Cleveland, OH – A groundbreaking new study from the Cleveland clinic reveals that weight-loss surgery (bariatric or metabolic surgery) offers notable and lasting health advantages over medication alone for individuals grappling with obesity and type 2 diabetes. The research, published today in Nature Medicine, demonstrates that surgery not only leads to greater weight loss and improved blood sugar control, but also dramatically reduces the risk of serious long-term health complications and even mortality